Brief: Gensight Biologics Says Cash Runway Extended To End Of July, Interim Financial Statement Postponed

Gensight Biologics SA

20/07/2023 06:36

July 20 (Reuters) - Gensight Biologics SA  SIGHT.PA :
    * GENSIGHT BIOLOGICS PROVIDES FINANCIAL AND OPERATIONAL
UPDATE
    * REPORTING OF INTERIM FINANCIAL STATEMENTS AS OF JUNE 30
POSTPONED TO SEPTEMBER 15, 2023
    * CASH RUNWAY EXTENDED TO END OF JULY 2023 TO PURSUE
FINANCING
ONGOING ADVANCED DISCUSSIONS WITH A LIMITED NUMBER OF EXISTING
AND NEW INVESTORS
    * OPERATING CASH BURN SIGNIFICANTLY REDUCED GOING FORWARD TO
LIMIT
FINANCING NEEDS IN 2024
    * COMPANY IS ALSO ADVANCING A NUMBER OF DISCUSSIONS WITH
POTENTIAL
PARTNERS ON STRATEGIC OPPORTUNITIES, INCLUDING MERGER OR
ACQUISITION, ASSESSED AS ONE OF RELEVANT OPTIONS TO MOVE FORWARD

Source text for Eikon:  ID:nBw1FmHM9a 
Further company coverage:  SIGHT.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))